Prostaglandin analog therapy challenges and innovation in glaucoma therapeutics
Glaucoma management primarily relies on prostaglandin analogs (PGAs) for effective intraocular pressure reduction. However, chronic PGA use frequently leads to ocular and periocular side effects such as conjunctival hyperemia, eyelash growth, and irreversible iris pigmentation, significantly affecti...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wolters Kluwer Medknow Publications
2026-03-01
|
| Серія: | Indian Journal of Ophthalmology |
| Предмети: | |
| Онлайн доступ: | https://journals.lww.com/10.4103/IJO.IJO_2387_25 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|